Massachusetts General Hospital

Massachusetts General Hospital, (Mass General) was established in 1811 in Boson, Massachusetts. Mass Geneeral is the teaching hospital for Harvard. MGH is part of the large medical science research and patient care complex that is consistently rated in the top 10 of teaching hospitals in the USA. MGH is noted for its work in endocrinology, cancer, digestive disorders, neurosurgery, and recently made signiificant break through in organ transplant rejection research.

Address
55 Fruit Street Boston, MA 02114
Website
http://www.massgeneral.org/default.aspx
Wikipedia
http://en.wikipedia.org/wiki/Massachusetts_General_Hospital

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Diseases, Conditions, Syndromes

Researchers show children are silent spreaders of SARS-CoV-2

In the most comprehensive study of COVID-19 pediatric patients to date, Massachusetts General Hospital (MGH) and Mass General Hospital for Children (MGHfC) researchers provide critical data showing that children play a larger ...

Diseases, Conditions, Syndromes

COVID-19 cytokine storms may prevent a durable immune response

Shiv Pillai, MD, Ph.D., investigator in the Ragon Institute of MGH, MIT and Harvard and professor at Harvard Medical School (HMS), recently published a paper in Cell showing that high levels of some cytokines seen in COVID-19 ...

Oncology & Cancer

Markers may predict patient response to immune therapy of cancer

For many individuals with different types of cancer, immune checkpoint inhibitors can effectively boost their immune system to fight their disease, but not all patients benefit from these medications. Now a team led by investigators ...

HIV & AIDS

Unique HIV reservoirs in elite controllers

Xu Yu, MD, Ragon group leader, recently published a study entitled "Distinct viral reservoirs in individuals with spontaneous control of HIV-1," in Nature. Yu's lab, in collaboration with Ragon group leaders Mathias Lichterfeld, ...

Diseases, Conditions, Syndromes

Investigational ALS drug generates promising clinical trial results

An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators ...

page 1 from 2